Several studies have found genetic association between the EN2 gene and autism. In particular, studies have found associations in the Chinese Han population as well as AGRE, NIMH and CPEA cohorts. However, another study found no genetic association between EN2 and autism in an AGRE cohort (Zhong et al., 2003).
Molecular Function
The encoded protein is a transcription factor.
External Links
References
Type
Title
Type of Disorder
Associated Disorders
Author, Year
Primary
Association of the homeobox transcription factor, ENGRAILED 2, 3, with autism spectrum disorder.
Model Type:
Genetic
Model Genotype:
Homozygous
Mutation:
Targeted deletion of the two Pax2/5/8-binding sites in En2 locus by homologous recombination with neo casette (PBDNEO).
Allele Type: Targeted (Deletion)
Strain of Origin: 129/SvEv
Genetic Background: Not Specified
ES Cell Line: R1; W4
Mutant ES Cell Line: Not Specified
Model Source: Not Specified
Model Type:
Genetic
Model Genotype:
Homozygous
Mutation:
Cre/loxP mediated deletion of En2 Pax2/5/8-binding sites (PBD).
Allele Type: Targeted (Deletion)
Strain of Origin: 129/SvEv
Genetic Background: Not Specified
ES Cell Line: R1; W4
Mutant ES Cell Line: Not Specified
Model Source: Not Specified
Model Type:
Genetic
Model Genotype:
Homozygous
Mutation:
Targeted deletion of homeobox domain (HD) of En2 gene.
Allele Type: Targeted (Deletion)
Strain of Origin: C57BL/6; BALB/c
Genetic Background: C57BL/6; CD1; 129/Sv
ES Cell Line: D3
Mutant ES Cell Line: Not Specified
Model Source: Not Specified
Model Type:
Genetic
Model Genotype:
Heterozygous
Mutation:
Targeted deletion of homeobox domain (HD) of En2 gene.
Allele Type: Targeted (Deletion)
Strain of Origin: C57BL/6; BALB/c
Genetic Background: C57BL/6; CD1; 129/Sv
ES Cell Line: D3
Mutant ES Cell Line: Not Specified
Model Source: Not Specified
Model Type:
Genetic
Model Genotype:
Homozygous
Mutation:
Targeted deletion of exon 1 including N-terminal (NTD) of En2 gene.
Allele Type: Targeted (Deletion)
Strain of Origin: C3H
Genetic Background: CD1; 129/Sv
ES Cell Line: D3
Mutant ES Cell Line: Not Specified
Model Source: Not Specified
Description: Abnormal location of boundary between anterior and posterior cerebellum at the base of intercrural fissure between vi and vii lobes and abnormal staining pattern in 4 regions of cerebellum: crus i, crus ii, paramedial lobe, paraflocculus, and lobe viii & ix
Exp Paradigm: Detection of lacz expression under en-2 enhancer and promoter restricted to granular and molecular layers
Description: Decreased cerebellar anlage size; decreased extent of fusion of cerebellar rudiments; decreased size of cerebellum and colliculi
Exp Paradigm: Dissection and histological analysis
Description: Abnormal fissure formation; developmental delay; abnormal development of posterior fissure 2/py; abnormal ixth lobe shape and size; no change in anterior region of cerebellum
Exp Paradigm: Analysis of mid-line sagittal cresyl-violet stained sections
Description: Decreased cerebellar size, both rostro-caudally and in the mediolateral expansion; abnormal foliation with abnormal fissure pattern, altered branching pattern, and decreased extent of the lobules
Exp Paradigm: Microscopic examination of brain
Description: Increased levels of serotonin, 5-hydroxyindolacetic acid in cerebellum; no change in level in hippocampus, striatum, and frontal cortex
Exp Paradigm: Hplc-electrochemical detection
Description: Increased susceptibility to kainic acid induced seizures with progression to severe tonic-clonic seizures
Exp Paradigm: Response to 20 mg/kg dose of kainic acid injection
Description: Decreased juvenile play, like chasing, pushing under, crawling over the partner, social sniffing, and allogrooming
Exp Paradigm: General observations
Description: Decreased spatial learning; deficit in performance of hidden platform taks; longer escape latency
Exp Paradigm: Hidden platform test for spatial memory and navigation.
Description: Decreased levels in hippocampus and cerebral cortex; increased levels in ventral midbrain and cerebellum
Exp Paradigm: En2 mrna expression